305 related articles for article (PubMed ID: 7333766)
1. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure.
Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H
Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766
[No Abstract] [Full Text] [Related]
2. [EEG pattern indicative of dialysis encephalopathy].
Dobato JL; Caminero AB
Neurologia; 1999 Jan; 14(1):35. PubMed ID: 10079690
[No Abstract] [Full Text] [Related]
3. [Current concepts of the role of aluminum in chronic kidney failure patients].
Gruev I; Belovezhdov N
Vutr Boles; 1983; 22(2):1-4. PubMed ID: 6362201
[No Abstract] [Full Text] [Related]
4. Epidemiology of aluminium toxicity in a 'low incidence' area.
Winney RJ; Cowie JF; Cumming AD; Short AI; Smith GD; Robson JS
Contrib Nephrol; 1984; 38():47-58. PubMed ID: 6713900
[No Abstract] [Full Text] [Related]
5. [Treatment of dialysis encephalopathy with deferoxamine].
Starkstein S; Berthier M; Nogués M; Leiguarda R
Medicina (B Aires); 1986; 46(3):327-31. PubMed ID: 3574092
[No Abstract] [Full Text] [Related]
6. [Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)].
Buge A; Poisson M; Masson S; Bleibel JM; Lafforgue B; Raymond P; Jaudon MC
Nouv Presse Med; 1978 Jun; 7(23):2053-9. PubMed ID: 673773
[TBL] [Abstract][Full Text] [Related]
7. Whole body aluminium in chronic renal failure and dialysis encephalopathy.
Williams ED; Elliott HL; Boddy K; Haywood JK; Henderson IS; Harvey I; Kennedy AC
Clin Nephrol; 1980 Oct; 14(4):198-200. PubMed ID: 6775855
[TBL] [Abstract][Full Text] [Related]
8. Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.
Lillevang ST; Pedersen FB
Nephrol Dial Transplant; 1989; 4(7):676. PubMed ID: 2510071
[No Abstract] [Full Text] [Related]
9. Dialysis encephalopathy: recovery after interruption of aluminium intake.
Poisson M; Mashaly R; Lebkiri B
Br Med J; 1978 Dec; 2(6152):1610-1. PubMed ID: 728750
[No Abstract] [Full Text] [Related]
10. [Effect on serum aluminium levels of continued ingestion of aluminium gels by patients with chronic renal insufficiency (author's transl)].
Boukari M; Rottembourg J; Jaudon MC; Clavel JP; Legrain M; Galli A
Nouv Presse Med; 1978 Jan; 7(2):85-8. PubMed ID: 349501
[TBL] [Abstract][Full Text] [Related]
11. Risk of orally administered aluminium hydroxide and results of withdrawal.
Bournerias F; Monnier N; Reveillaud RJ
Proc Eur Dial Transplant Assoc; 1983; 20():207-12. PubMed ID: 6657657
[TBL] [Abstract][Full Text] [Related]
12. A fatal case of aluminium encephalopathy in a patient with severe chronic renal failure not on dialysis.
Zatta P; Zambenedetti P; Reusche E; Stellmacher F; Cester A; Albanese P; Meneghel G; Nordio M
Nephrol Dial Transplant; 2004 Nov; 19(11):2929-31. PubMed ID: 15496577
[No Abstract] [Full Text] [Related]
13. Reversible dialysis encephalopathy: role for aluminium-containing gels.
Masselot JP; Adhemar JP; Jaudon MC; Kleinknecht D; Galli A
Lancet; 1978 Dec 23-30; 2(8104-5):1386-7. PubMed ID: 82892
[No Abstract] [Full Text] [Related]
14. [The causes of aluminum cumulation and poisoning in patients with chronic kidney failure treated by hemodialysis on a regular program and the possibilities for therapy].
Válek A; Sulková S; Laurinová Z
Ter Arkh; 1991; 63(6):89-93. PubMed ID: 1948757
[No Abstract] [Full Text] [Related]
15. Dialysis encephalopathy in a non-dialysed uraemic boy treated with aluminium hydroxide orally.
Nathan E; Pedersen SE
Acta Paediatr Scand; 1980 Nov; 69(6):793-6. PubMed ID: 7211365
[TBL] [Abstract][Full Text] [Related]
16. [The natural history of dialysis encephalopathy (author's transl)].
Pogglitsch H; Wawschinek O; Holzer H; Petek W; Ladurner G; Katschnig H; Korthals C
Acta Med Austriaca; 1980; 7(3):71-6. PubMed ID: 7223340
[TBL] [Abstract][Full Text] [Related]
17. [Pseudo-porphyria cutanea tarda in patients with chronic renal insufficiency and in patients with renal transplants].
Antonello A; Peserico A; Corsano A; Zannini G; Fagiolo U
Minerva Chir; 1980 May; 35(10):775-7. PubMed ID: 7005735
[No Abstract] [Full Text] [Related]
18. The dialysis encephalopathy syndrome. Possible aluminum intoxication.
Alfrey AC; LeGendre GR; Kaehny WD
N Engl J Med; 1976 Jan; 294(4):184-8. PubMed ID: 1244532
[TBL] [Abstract][Full Text] [Related]
19. [Serum aluminum in hemodialysis patients. Relation to osteodystrophy, encephalopathy and aluminum hydroxide consumption].
Nielsen LP; Heaf JG
Ugeskr Laeger; 1983 May; 145(18):1363-7. PubMed ID: 6868163
[No Abstract] [Full Text] [Related]
20. Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine.
Mudde AH; Roodvoets AP; Van Groningen K
Neth J Med; 1985; 28(1):6-11. PubMed ID: 3974771
[No Abstract] [Full Text] [Related]
[Next] [New Search]
